Interestingly, the Bre–Ved–ZA ADC strongly inhibits the proliferation of CD30+ tumor cells, and this effect is accompanied by a stronger increment of apoptosis activating Caspase 3/7 compared to that triggered by Bre–Ved. This evidence concerns the gene CASP3 and neoplasm.